Collaboration will explore nutrition as a key driver of cardiovascular health through collaborative research led by Dr. Harold Schmitz

AUSTIN, Texas, Sept. 8, 2026 /PRNewswire/ -- Humann, the Austin-based cardiovascular health supplement company, continued its legacy of engaging with leading academic institutions by announcing an academic research partnership with the University of California, Davis, a globally recognized leader in nutrition, food, and health sciences research. Dr. Harold Schmitz, Ph.D., has been appointed as Chair of the Humann science advisory board, and will lead this research initiative. This partnership with UC Davis and its Innovation Institute for Food and Health (IIFH) aims to investigate how precision nutrition approaches can improve cardiovascular health, performance, and longevity, building a stronger scientific foundation for future innovation in the food and dietary supplements categories.

Dr. Harold Schmitz brings extensive experience in nitric oxide research and in driving science-based food and nutrition innovation spanning academia and industry, including serving as Chief Science Officer at Mars, Inc and Senior Scholar at the UC Davis Graduate School of Management. In his role as Chair of the Humann science advisory board, Dr. Schmitz will lead the partnership with IIFH that will design and conduct scientific research, including clinical trials, to advance knowledge regarding the critical intersection of nutrition and cardiovascular health in women and men across multiple life stages.

"Humann started with the belief that nutrition can play a meaningful role in supporting cardiovascular health, but we've always known there is much more to discover," said Joel Kocher, CEO and Co-Founder of Humann. "Scientific partnerships have always been central to how we build this company, and our collaboration with IIFH gives us the opportunity to deepen our understanding of how nutrition can support cardiovascular health."

As more consumers take a proactive approach to healthy aging, the partnership reflects a growing recognition that longevity is shaped by interconnected factors, with the intersection of cardiovascular health and nutrition playing a central role. Together, Humann and IIFH aim to understand how cardiovascular nutrition supports optimal health and longevity, moving the conversation about cardiovascular health into the realm of improving quality of life and performance for all women and men based on rigorous scientific research.

Born out of research from The University of Texas, Humann's commitment to science has been at the core of the company since its founding. This foundation has been strengthened by the expertise of partnering with renowned scientific leaders, including Dr. John Ivy, whose research has advanced our understanding of exercise, metabolism and nutrition; Dr. John Cooke, a pioneering cardiologist, researcher and academic leader whose work has helped shape modern cardiovascular health and nitric oxide research; and the late Nobel Laureate Dr. Ferid Murad, whose discovery of nitric oxide's role in cardiovascular signaling transformed the field of cardiovascular health. This partnership with UC Davis will enable new studies to build on Humann's growing body of scientific research, including eight previously published clinical studies on its products.

"We believe it's time to reframe the conversation around heart health because, for too long, America has been looking at it the wrong way. The focus has been on reacting to disease instead of supporting cardiovascular health before problems arise. We believe science-based nutrition has an essential role to play in changing that," said Kocher.

"Cardiovascular health is a critical driver of longevity as well as optimal physical and mental performance throughout all stages of life," said Dr. Harold Schmitz, incoming Chair of the Science Advisory Board at Humann. "Nutrition can play a defining role in blood pressure, cholesterol levels, blood sugar, and other factors that work together to define cardiovascular health over time. Humann has long been committed to advancing the science of cardiovascular health, and this partnership with UC Davis emphasizes Humann's continued commitment to rigorous research and scientific leadership. This collaboration will advance both science and public understanding regarding cardiovascular health and nutrition, and accelerate innovation that can improve cardiovascular health for consumers everywhere."

"UC Davis has long been a leader at the interface of advanced technology and nutrition science, including cardiovascular nutrition. This collaboration creates an exciting opportunity to leverage cutting edge technologies to deepen our understanding of the connections between nutrition, cardiovascular health, and healthy aging," said Justin Siegel, Faculty Director of the Innovation Institute for Food and Health at UC Davis. "By combining complementary expertise, we can accelerate research that advances scientific knowledge and its translation into practical insights positively impacting consumer health."

About Humann

Humann is building the new cardiovascular health standard, supporting heart health and overall wellness through science-backed cardiovascular supplementation. Best known for SuperBeets®, the #1 cardiologist recommended beet brand for heart health support, Humann focuses on supporting healthy blood flow to help deliver oxygen and nutrients throughout the body. Founded through academic and scientific research at The University of Texas, Humann brings clinically studied ingredients and physician-aligned innovation into daily routines. Humann is trusted by more than 2,000 collegiate and professional sports programs and used by thousands of medical practitioners nationwide. Humann's products are available in more than 30,000 retail locations and on humann.com.

About the UC Davis Innovation Institute for Food & Health

The UC Davis Innovation Institute for Food & Health (IIFH) works to make the food we love healthier for all people and the planet. By leveraging strategic partnerships with leading food companies, investors, foundations, entrepreneurs, and academics, IIFH drives interdisciplinary research and accelerates the commercialization of groundbreaking technologies. The Institute creates impact across four core areas: breakthrough research that advances healthier foods and ingredients; talent development that cultivates the next generation of innovators; uncommon connections that unite diverse partners across the ecosystem; and market impact that enables new products and companies to improve health while preserving the joy of eating.

Media Contacts

Paul Street 

Madeleine Worrall

[email protected]

UC Davis Innovation Institute for Food & Health

Marissa Pickard

[email protected] 

SOURCE Humann

Share this article

La Fundación Bulat Utemuratov destina 460 millones de tenge para apoyar el proyecto de gasificación de Almaty

ALMATY, Kazakstán, 8 de septiembre de 2026 /PRNewswire/ -- La Fundación Bulat Utemuratov anunció una asignación de 460 millones de tenge (aproximadamente 1 millón de dólares estadounidenses) para apoyar la gasificación de viviendas particulares en Almaty. Esta iniciativa, puesta en marcha en colaboración con el Akimat (Alcaldía) de la ciudad de Almaty, busca desarrollar la infraestructura urbana, mejorar las condiciones de vida y la calidad del aire de la ciudad.

Según un memorando recientemente firmado, el Akimat de la ciudad de Almaty inspeccionará las viviendas particulares, asesorará a los residentes sobre el proceso de conexión y les brindará apoyo integral para la transición a la calefacción con gas natural. Posteriormente, contratistas cualificados llevarán a cabo las obras de construcción e instalación necesarias.

Darkhan Satybaldy, alcalde de Almaty, destacó: "Continuamos trabajando específicamente para conectar las viviendas particulares a la red de suministro de gas de la ciudad. Los requisitos varían en cada caso, por lo que es fundamental brindar un apoyo integral a los residentes, desde las consultas hasta la conexión propiamente dicha, además del trabajo técnico. El apoyo de las empresas socialmente responsables nos permite ampliar esta iniciativa".

La transición del carbón al gas natural en los hogares es un paso crucial para mejorar la calidad del aire en Almaty. Durante la temporada de calefacción, el uso de combustibles sólidos en el sector privado sigue siendo una importante fuente de contaminación.

Ainur Karbozova, consejera delegada de la Fundación Bulat Utemuratov, señaló: "Para nosotros es importante apoyar un proyecto destinado a desarrollar la infraestructura urbana y crear mejores condiciones de vida para los residentes de Almaty. La gasificación del sector privado permitirá a las familias que aún no están conectadas a la red de gas acceder a un sistema de calefacción moderno. Nos complace apoyar esta iniciativa de la ciudad".

Este proyecto de gasificación se basa en el compromiso duradero de la Fundación con Almaty. Entre las iniciativas previas en la ciudad se incluyen la reconstrucción integral del Jardín Botánico, la modernización de los sistemas de ventilación y aire acondicionado del Museo Nacional Central de la República de Kazajstán y la apertura de uno de los primeros Centros Asyl Miras para el Autismo. Durante la pandemia de COVID-19, la Fundación también apoyó al sistema de salud local mediante la instalación de laboratorios móviles de pruebas PCR.

Share this article

SALT LAKE CITY, Sept. 8, 2026 /PRNewswire/ -- An extensive, first-of-its-kind research study by ARUP Laboratories clarifies the clinical value of atypical findings from prenatal cell-free DNA (cfDNA) screening and their impact on pregnancy outcomes. The study, which investigated the connection between atypical prenatal cfDNA screening results and the diagnostic yield of follow-up testing, found that atypical findings frequently indicate clinically relevant diagnoses.

"No one has conducted a study as large as this on atypical findings," said Katie Rudd, PhD, FACMG, ARUP medical director of Cytogenetics and Genomic Microarray. She and her peers analyzed more than 10 years of data and more than 200 cases with atypical cfDNA findings and follow-up prenatal, postnatal, or maternal testing.

"Why Atypical Findings Matter: Follow Up Testing Finds Diagnostic Results Related to cfDNA Screen," by authors Rebekah Whitham, BS, MA, Hannah S. Anderson, MS, LCGC, Danielle LaGrave, MS, LCGC, Lauren Wallace, MS, LCGC, and Rudd, was published in Genetics in Medicine, an official journal of the American College of Medical Genetics and Genomics (ACMG).

Prenatal cfDNA screening is noninvasive, blood-based testing used to assess fetuses for common chromosomal abnormalities, such as Patau syndrome (trisomy 13), Edward syndrome (trisomy 18), and Down syndrome (trisomy 21). Atypical results have increased in recent years, likely due to improving technology and broader screening efforts, said Rudd. The uncertainty of these results makes it difficult for providers and patients to determine a clear path forward.

"When healthcare providers or patients receive atypical results from cfDNA screening, they don't know what to make of them—the results could be benign or pathogenic, associated with the pregnancy or with the mom," Rudd said. "The findings of this study indicate that atypical results shouldn't be ignored and that they provide important clues for clinical management."

Prenatal cfDNA screening is used to identify risk of genetic disorders and minimize the need for more invasive diagnostic testing procedures, such as chorionic villus sampling or amniocentesis, which carry a slight risk of pregnancy loss. With a better understanding of what atypical results mean, providers and patients can identify their next course of action, such as whether diagnostic follow-up testing is necessary.

The study found that 50% (102 of 204) of atypical cfDNA cases had at least one abnormal result identified by follow-up diagnostic testing. Of these cases, 55 abnormal results were determined to be pathogenic, 18 identified variants of uncertain significance, and eight were likely benign. Copy number variations, or aberrations in the number of copies of a DNA sequence, were the most common diagnostic finding, but findings also included aneuploidy, chromosome rearrangement, and others.

Wallace, who spent a decade working as a maternal-fetal medicine genetic counselor in a high-risk pregnancy clinic before joining ARUP, always found patient consultations regarding atypical results to be particularly challenging.

"For patients, it's incredibly emotional and anxiety inducing to receive atypical results," Wallace said. "As clinical providers, we have wanted data around what these findings could mean for a long time and to know how best to further investigate them."

cfDNA screening can also identify maternal genetic anomalies that may not be present in the pregnancy.

"We found a surprisingly high percentage of maternal findings, which are often more benign than findings related to baby," Wallace said. These findings indicate that maternal testing may offer valuable insights and serve as an intermediary testing option before more invasive procedures.

Wallace and Rudd emphasized that the findings of this study indicate there is value in reporting and investigating atypical cfDNA results.

Read the full publication to learn more: https://www.gimjournal.org/article/S1098-3600(26)01031-2/abstract.

About ARUP Laboratories

Founded in 1984, ARUP Laboratories is a leading national reference laboratory and a nonprofit enterprise of the Spencer Fox Eccles School of Medicine at the University of Utah and its Department of Pathology. ARUP offers more than 3,000 tests and test combinations, ranging from routine screening tests to esoteric molecular and genetic assays. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™. ARUP is ISO 15189 and CAP accredited. For more information, visit www.aruplab.com.

Media Contact

Bonnie Stray

801-583-2787 ext. 2823

[email protected] 

SOURCE ARUP Laboratories

Share this article

LumApps ernennt Sébastien Cano zum neuen Chief Executive Officer

LYON, France und AUSTIN, Texas, 8. September 2026 /PRNewswire/ -- LumApps, der Marktführer für Employee-Experience-Plattformen, ernennt Sébastien Cano mit Wirkung zum 1. Dezember 2026 zum Chief Executive Officer (CEO). Der aktuelle CEO und Gründer Sébastien Ricard übernimmt künftig die Position des Executive Chairman.

Der Führungswechsel markiert eine entscheidende Entwicklungsphase für LumApps. Das Unternehmen erreicht eine neue globale Größenordnung und vernetzt heute täglich Millionen von Mitarbeitenden – vom Schreibtisch bis zu den operativen Teams. In seiner Rolle als Executive Chairman wird sich Ricard auf die langfristige strategische Ausrichtung und Governance konzentrieren, während er das operative Tagesgeschäft an Cano übergibt.

Sébastien Cano bringt mehr als 20 Jahre Führungserfahrung in der Enterprise-Softwarebranche mit. Bei den globalen Technologiekonzernen Thales und Gemalto skalierte er erfolgreich wachstumsstarke Technologieunternehmen zu globalen Marktführern. Seine Priorität bei LumApps: Die Roadmap unseres Workhubs beschleunigen und den messbaren Mehrwert für Kunden weltweit steigern.

„Vor über zehn Jahren sind wir mit einer klaren Mission gestartet: Wir unterstützen Organisationen dabei, alle Mitarbeitenden zu vernetzen, zu informieren und zu begeistern – egal, wo sie arbeiten", erklärt Sébastien Ricard, Gründer und künftiger Executive Chairman. „Dank unserer Kunden und Partner ist LumApps heute der globale Marktführer für Employee Experience. Für unsere nächste Wachstums- und Innovationsphase ist Sébastien Cano mit seiner tiefgreifenden Enterprise-Expertise genau der richtige CEO. Er ist die ideale Führungspersönlichkeit, um LumApps weiter voranzubringen."

„LumApps hat eine herausragende Plattform, ein starkes Team und immenses Vertrauen bei globalen Unternehmen aufgebaut", so Sébastien Cano, designierter CEO. „Ich freue mich darauf, eng mit unseren Kunden, Partnern und Teams zusammenzuarbeiten. Unser Ziel ist klar: Wir beschleunigen unsere Produkt-Roadmap und stellen sicher, dass jedes Teammitglied in einer KI-gestützten Arbeitswelt den maximalen Nutzen aus unserer Plattform zieht."

Über LumApps

LumApps AI ist der zentrale Hub, der Menschen, Tools und Wissen in einer intelligenten Employee Experience verbindet. Statt KI als isoliertes Werkzeug zu betreiben, orchestriert die Plattform KI-Agenten direkt im täglichen Arbeitsfluss. Durch gezielte Micro-Apps übernehmen diese Agenten administrative Routineaufgaben und machen abstrakte Technologie im Alltag produktiv nutzbar.

Mit nativen Integrationen für Microsoft 365 und Google Workspace sichert LumApps AI über 10 Millionen Nutzenden weltweit eine messbar höhere Effizienz. Gartner® und Forrester® zeichnen die Plattform kontinuierlich als Leader aus und bestätigen damit die führende Rolle von LumApps bei der Evolution moderner Arbeitsplatz- und Intranet-Lösungen.

Weitere Informationen unter www.lumapps.com.

KONTAKT: [email protected]

Share this article

LumApps nomme Sébastien Cano au poste de Chief Executive Officer

AUSTIN, Texas et LYON, France, 8 septembre 2026 /PRNewswire/ -- LumApps, leader du marché des plateformes d'expérience collaborateur, annonce aujourd'hui la nomination de Sébastien Cano au poste de Chief Executive Officer à compter du 1er décembre 2026. Sébastien Ricard, fondateur et actuel CEO, deviendra Executive Chairman de l'entreprise.

Cette évolution intervient à un moment clé du développement de LumApps, qui accompagne aujourd'hui des millions de collaborateurs dans le monde, au bureau comme sur le terrain. En tant qu'Executive Chairman, Sébastien Ricard restera pleinement impliqué dans la stratégie à long-terme de LumApps, tandis que Sébastien Cano en prendra la direction générale.

Sébastien Cano apporte à LumApps plus de vingt ans d'expérience dans le secteur des logiciels d'entreprise, avec un parcours marqué par le développement et l'expansion internationale de sociétés technologiques à forte croissance. Il a notamment exercé des fonctions de direction chez Thales et Gemalto, où il a piloté le développement d'activités à l'échelle mondiale. Dans ses nouvelles fonctions, il aura pour priorité de concrétiser la vision produit de LumApps orientée vers le Workhub et d'accroître la valeur apportée à chaque client.

« Il y a plus de dix ans, nous avons fondé LumApps avec un objectif simple : transformer la façon dont les entreprises connectent, informent et engagent chacun de leurs collaborateurs, où qu'ils se trouvent », déclare Sébastien Ricard, fondateur et futur Executive Chairman. « Grâce à nos clients et partenaires, LumApps est devenu le leader mondial de l'expérience collaborateur. Alors que nous entrons dans une nouvelle phase majeure d'innovation et de croissance, le parcours de Sébastien Cano et son expérience du développement d'entreprises technologiques à l'international font de lui le dirigeant idéal pour accompagner LumApps dans cette nouvelle étape. »

« LumApps a construit une plateforme exceptionnelle, constitué une équipe de très haut niveau et bâti une marque qui a gagné la confiance d'entreprises de toutes tailles à travers le monde », déclare Sébastien Cano, futur Chief Executive Officer. « Depuis notre siège américain basé à Austin, au Texas, j'ai hâte de travailler aux côtés de nos clients, de nos partenaires et de nos équipes partout dans le monde pour continuer à tenir nos engagements sur chacun de nos marchés. Je suis très heureux de rejoindre LumApps à ce moment clé de son histoire. Ma priorité sera d'accélérer la feuille de route vers le Workhub et de permettre à chaque collaborateur d'en tirer le meilleur parti, à l'heure où l'IA transforme profondément le travail. »

À propos de LumApps

LumApps AI est l'AI Employee Hub où collaborateurs et agents IA travaillent ensemble pour transformer les investissements dans l'IA en adoption au quotidien. La plateforme propose un portefeuille complet de services aux collaborateurs et d'agents IA couvrant les tâches et workflows du quotidien, afin d'offrir aux entreprises une voie concrète vers une adoption de l'IA à grande échelle.

Intégrée à Google Workspace et Microsoft 365, LumApps accompagne plus de 10 millions d'utilisateurs dans le monde et est reconnue Leader des solutions intranet par Gartner® et Forrester®.

Pour en savoir plus, rendez-vous sur www.lumapps.com.

CONTACT: [email protected]

Share this article

Specialized groups of AI agents continuously ingest, quantify, prioritize, govern and act on cyber risk, with human approval before any action is executed

BOISE, Idaho, Sept. 8, 2026 /PRNewswire/ -- Quantara AI, the AI-native cyber risk intelligence company, today announced the general availability of the Quantara AI Agent Network, a coordinated network of specialized agent groups that continuously turns thousands of technical findings into dollar-ranked cyber risk actions and decisions. The agents pull exposure, threat, control and financial data from tools customers already own, price what each risk could cost the business, and rank fixes by risk reduced per dollar spent. Quantara AI Agent Network continuously:

- Transforms cyber, threat, control and business signals into financially prioritized, human-approved actions.

- Quantifies material cyber exposures in dollars and ranks remediation by expected risk reduction and ROI.

- Surfaces the top 1% of exposures driving potential business loss so organizations can focus resources where they matter most.

Security teams do not lack findings. They lack a continuously updated, defensible way to determine which risks to fix first and prove the value of remediation. According to IDC FutureScape: Worldwide Security and Trust 2026 Predictions, by 2028, 40% of enterprises will use autonomous, agent-driven platforms to quantify cyber risk, turning security metrics into financial exposure insights, guiding budgets, controls, and M&A risk assessments.

A Network of Specialized Agents

The Quantara AI Agent Network coordinates specialized groups of agents across the cyber risk lifecycle:

- Ingest Agents connect cyber exposure, threat, endpoint, cloud, control and business systems and keep the signal current.

- Context Agents correlate exposures with assets and map them to business units and processes in a unified risk model.

- Risk Agents translate exposure into financial risk presented as Value at Risk (VaR) and surface the top 1% driving material loss.

- Govern Agents evaluate risk appetite, assumptions and frameworks (NIST, CIS, ISO, etc.) and route proposed actions for human approval.

- Act Agents move approved actions into workflows, ticketing tools and the quantitative risk register, track remediation and report realized risk reduction to executives and the board.

"Cybersecurity has spent years getting better at finding problems. The next evolution is using agentic intelligence to continuously determine which of those problems really matter to the business and what should happen next," said Harish Barnela, Founder and CEO of Quantara AI. "Our Agent Network connects cyber, threat, business and financial context and quantifies exposure and expected risk reduction in dollars. The result is a more defensible way for CISOs and boards to decide where to focus, what to fund and what return to expect."

From Thousands of Findings to the Risks That Matter

In a recent enterprise engagement, Quantara connected security signals across multiple domains with business and financial context, narrowing thousands of technical findings to the risks with the greatest potential business impact and prioritizing actions based on expected risk reduction.

Availability

The Quantara AI Agent Network is available now to enterprises, MSSPs and vCISOs as part of the Quantara AI platform. It integrates with CrowdStrike, SentinelOne, Wiz, Tenable, Rapid7, Qualys, Splunk, Microsoft, ServiceNow, AWS and other leading exposure, endpoint, cloud and workflow tools. Demos are available at https://quantara.ai.

About Quantara AI

Quantara AI is an AI-native cyber risk intelligence platform that identifies the top 1% of exposures that matter, quantifies them in dollars and prioritizes fixes by ROI. Built for CISOs, CFOs, CROs and boards, it unifies continuous cyber risk quantification, exposure intelligence, control assessment and executive reporting with human oversight at every decision point. Quantara AI is SOC 2 Type 2 certified and headquartered in Boise, Idaho.

Learn more at https://Quantara.ai.

Media inquiries: [email protected]

SOURCE Quantara AI

Share this article

Arkestro recognized as a Sample Vendor for Supplier Discovery as we see enterprises look to strengthen supplier networks and respond faster to disruption

SAN FRANCISCO, Sept. 8, 2026 /PRNewswire/ -- Arkestro, the leading predictive procurement platform accelerating enterprise scale, today announced that it has been identified as a Sample Vendor in the Gartner® Hype Cycle™ for Multienterprise Solutions, 2026.

"As supplier networks become more complex, we believe predictive intelligence can give buyers more options and resilience while giving suppliers a more informed way to engage," said Rob DeSantis, Founder and CEO of Arkestro. "Competition will always be part of procurement, but it doesn't have to make buyer-supplier relationships adversarial when both sides have a better way to work together. To enable that collaboration, procurement technology must extend beyond the walls of the enterprise. Improving the decision-making process for both procurement teams and suppliers will enhance value across the supply chain, not just the processes happening inside either organization."

Arkestro was named a Sample Vendor for Supplier Discovery, which Gartner defines as solutions that assist organizations in identifying, assessing and incorporating new supply sources for goods and services within their procurement processes.

The report notes that these solutions generally maintain an extensive database of supplier information and frequently utilize artificial intelligence and graph technologies to match sourcing criteria with potential suppliers, thereby optimizing the competitiveness of the supplier portfolio. To us, Gartner also cites supply chain disruptions, capacity constraints, cost optimization strategies, and innovation targets as reasons procurement teams need to efficiently identify and qualify alternative suppliers.

We feel the report further notes that Supplier Discovery is increasingly being embedded within third-party risk management, supplier risk management, source-to-pay and other procurement platforms, making it a feature of broader procurement technology rather than a distinct market.

The announcement follows Arkestro's fourth consecutive recognition as a Sample Vendor in the Gartner Hype Cycle for Procurement and Sourcing Solutions, 2026, where the company was named in the Supplier Discovery and Autonomous Sourcing categories.

To view the full Hype Cycle for Multienterprise Solutions, 2026 report, visit https://arkestro.com/spotlight/gartner/. Learn more about Arkestro at www.arkestro.com and connect with Arkestro at the Gartner Procurement Conference 2026 in San Diego, California, September 15-16, 2026.

Gartner Disclaimer:

Gartner does not endorse any company, vendor, product or service depicted in its publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner publications consist of the opinions of Gartner's business and technology insights organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this publication, including any warranties of merchantability or fitness for a particular purpose.

GARTNER and HYPE CYCLE are trademarks of Gartner, Inc. and/or its affiliates.

About Arkestro

Arkestro is the leading predictive procurement platform, accelerating enterprise spend transformation and supply chain agility. By combining AI and game theory with Arkestro's patented three science technologies—Negotiation Science, Supplier Science, and Process Science—Arkestro shifts traditional procurement to become a proactive, results-driven function. Trusted by Fortune 500 companies across industries, Arkestro unlocks trapped savings, optimizes negotiations, and enhances supplier collaboration. Arkestro is hosting its annual Optimal conference in Houston, TX, on October 13-15, 2026. Explore what it means to Unlock the Predictive Advantage and register here.

Media Contact

Cailey Henderson

LaunchSquad

SOURCE Arkestro

Share this article

Nationwide vote will help co-op allocate funding for trail advocacy, education and stewardship across all 50 states

SEATTLE, Sept. 8, 2026 /PRNewswire/ -- This National Public Lands Day on Sept. 26, REI Co-op is donating $1 million to support the trails that connect America. From Sept. 8 to Oct. 2, members, customers and employees can vote online or in REI stores to help decide how a portion of the donation is directed to eligible nonprofit organizations that care for America's National Scenic and Historic Trails.

Every participating trail organization will receive funding, with a portion of the funding guided by the vote. Together, these organizations support projects and partners across more than 60,600 miles of National Scenic and Historic Trails, from iconic routes like the Pacific Crest Trail and Appalachian Trail to local trail segments that connect communities to the outdoors.

"Our national trails give us room to breathe and help us feel connected to nature, to one another and to ourselves, so on National Public Lands Day, we're giving back to them," said Mary Beth Laughton, president and CEO of REI Co-op. "Through this effort, the co-op is turning appreciation into care, and we're inviting our members, customers and employees to join us. Together, we can help protect and support these trails and strengthen the organizations that steward them."

The effort is being launched with the Partnership for the National Trails System (PNTS), whose network includes organizations working across America's National Scenic and Historic Trails. Funding will support trail stewardship, volunteer engagement, youth leadership development, conservation advocacy and other efforts that help trails remain accessible, welcoming and maintained for future generations.

"We're proud to join REI in connecting people more deeply to the trails they love," said Courtney Lyons-Garcia, executive director of the Partnership for the National Trails System. "From trail maintenance and volunteer stewardship to advocacy and leadership development, this support will strengthen the projects and partners caring for some of America's most cherished outdoor places."

Get Involved on and Off the Trail

Supporting National Scenic and Historic Trails goes beyond a donation. Throughout September, more than 130 REI stores will host local trail organizations and community groups, helping people discover places to explore, connect with partners in their communities and find new opportunities to volunteer, advocate and care for public lands close to home. Learn more.

PNTS partner organizations will host hikes, stewardship projects, rides and outdoor events around the country, giving people opportunities to get outside and experience firsthand the trails and public lands they are helping support. Learn more.

Members and customers can stay engaged year-round through the REI Cooperative Action Network and REI Cooperative Action Fund, which advance conservation, civic engagement and community-led efforts that protect outdoor places and expand access to the outdoors.

Protecting public lands has long been central to REI's mission. For 50 years, the co-op has invested in stewardship, advocacy and community partnerships that help ensure outdoor places remain accessible, welcoming and cared for. This latest effort builds on that legacy while creating new opportunities for people to get involved and outside.

About the REI Co-op

REI is a specialty outdoor retailer, headquartered near Seattle. The nation's largest consumer co-op, REI is a growing community of 26 million members who expect and love the best quality gear and outstanding customer service. In addition to the co-op's many stores across the country, outdoor enthusiasts can shop at REI.com, REI Outlet or the REI shopping app. Everyone is welcome to shop REI, but members who join the co-op enjoy a range of benefits. REI is a purpose-driven and values-led company dedicated to enabling life outside for all.

About the Partnership for the National Trails System

The Partnership for the National Trails System (PNTS) is a nationwide nonprofit organization that connects, strengthens, and amplifies a vibrant network of partners united to preserve, enhance, and promote America's National Scenic and Historic Trails.

Legal Terms & Conditions

In celebration of National Public Land Day on September 26, 2026 ("NPLD"), REI shall donate $1,000,000 to Partnership for the National Trails System ("PNTS"). Donation shall be made through REI's Donor Advised Fund administered by the Seattle Foundation and shall be distributed in four portions: (1) $430,000 to be distributed equally amongst participating PNTS Trail Members; (2) $500,000 to a select subset of projects in alignment with the REI Member/Consumer Vote occurring September 8, 2026 – October 2, 2026. The percentage of funds donated to each category will be decided based on the total percentage of votes each category receives; (3) $50,000 to be retained by PNTS for operations; (4) $20,000 to be dedicated to at least 4 National Trails that do not have a currently designated trail partner.

SOURCE REI (Recreational Equipment, Inc.)

Share this article

NEW YORK, Sept. 8, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Unicycive Therapeutics, Inc. (NASDAQ: UNCY) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Unicycive securities between December 29, 2025 and June 29, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/cases/unicycive-therapeutics-inc-uncy-class_action_lawsuit.

Unicycive Case Details

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:

- Unicycive had not inspected its third-party manufacturing vendor's facility or otherwise audited the facility's compliance with current good manufacturing practices;

- consequently, Unicycive lacked a reasonable basis to believe that the vendor had remedied the deficiencies cited by the FDA;

- there was a material undisclosed risk that the FDA would require additional information concerning the vendor's manufacturing practices;

- as a result, regulatory approval of oxylanthanum carbonate was reasonably likely to be delayed; and

- accordingly, Defendants' positive statements concerning Unicycive's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis.

What's Next for Unicycive Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/cases/unicycive-therapeutics-inc-uncy-class_action_lawsuit. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Unicycive you have until November 2, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to Unicycive Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for Unicycive Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Contact Info

Peretz Bronstein, Esq. or Nathan Miller

Bronstein, Gewirtz & Grossman, LLC

917-590-0911 | [email protected]

Attorney advertising.

Prior results do not guarantee similar outcomes.

SOURCE Bronstein, Gewirtz & Grossman, LLC

Share this article

Unleashed brings together 20 personal stories, offering an honest look at life, movement, challenge, possibility and community through the voices of the people themselves.

Rather than defining individuals by a device, diagnosis, or moment in their journey, the book creates space for people to tell their stories in their own words and for the broader O&P community to listen.

"Unleashed started with a very simple idea:  give people the opportunity to tell their stories and make sure we are listening," said Sharon Gwynn, Manager, Community Impact & Strategic Communications at PROTEOR USA.  "But through this process, it became clear that the responsibility goes beyond simply sharing those voices.  If we want to truly serve this community, we need to be present in it, learn from it, and create opportunities for people to help shape what comes next."

That philosophy is helping guide the development of PROTEOR's broader Community Impact strategy as the company looks toward 2027 and beyond.

PROTEOR is currently engaging and listening across the O&P ecosystem including individuals with limb loss and limb difference, caregivers, clinicians, rehabilitation professionals, community organizations, and other stakeholders to better understand where meaningful gaps exist and where the company can responsibly contribute.

The goal is not to create programs for the community in isolation, but to identify opportunities to work with the community connecting people, resources, education, experiences, and voices in ways that can create lasting value.

"Our plans for 2027 are intentionally being shaped by what we are hearing now," Gwynn continued.  "We have ambitious plans to deepen PROTEOR's presence and participation within the community, but we also recognize that impact starts with listening.  We want the people we serve and the professionals and organizations supporting them to have a voice in determining where we can make the greatest difference."

The launch of Unleashed represents an early step in that broader commitment.

For PROTEOR, being Human First means looking beyond products and technology to the people, families, clinicians, and communities surrounding every mobility journey.  As the company develops its Community Impact strategy for 2027, that commitment will continue to center on listening, collaboration, connection, and elevating voices throughout the O&P community.

Unleashed: Real Stories of Strength, Independence, and Community will be introduced at the PROTEOR booth (313) during the 2026 AOPA National Assembly in Las Vegas, with additional availability through Amazon and BookBaby online booksellers.

About Unleashed

Unleashed: Real Stories of Strength, Independence, and Community is a collection of 20 personal stories highlighting the experiences, perspectives, and lives of individuals within the limb loss and limb difference community.  Developed by PROTEOR USA, the project was created to provide a platform for authentic voices and encourage greater connection and understanding throughout the broader community.

About PROTEOR

PROTEOR is a global leader in prosthetic and orthotic solutions dedicated to improving mobility and empowering people to live life on their own terms.  Guided by its Human First philosophy, PROTEOR combines innovations, clinical expertise, and collaboration with the people and professionals, it serves to advance mobility and improve lives.

Media Contacts

Eric Ferris

Vice-President, Global Marketing & Product Management

[email protected] | +1 855.450.7300 ext. 168

Sharon Gwynn

Manager, Community Impact & Strategic Communications

[email protected] | +1 855.450.7300 ext. 115

Alexandra Houiste

Global Marketing Activation & Communications Manager

[email protected] | +33 (0) 6 40 73 99 97

SOURCE PROTEOR

Share this article